Letter to the Editor: Chlorpromazine as a Viable Alternative to Midazolam for Palliative Sedation in a Liver Transplant Recipient with HCC: A Brief Communication
Restricted accessLetterFirst published online July, 2024
Letter to the Editor: Chlorpromazine as a Viable Alternative to Midazolam for Palliative Sedation in a Liver Transplant Recipient with HCC: A Brief Communication
SurgesSM, BrunschH, JaspersB, et al.Revised European Association for Palliative Care (EAPC) recommended framework on palliative sedation: An international Delphi study. Palliat Med, 2024; 38(2):213–228.
2.
TiefenthalerCM, HirstJM, EdmondsKP, et al.Chlorpromazine's potential role in palliating distressing symptoms associated with hyperactive delirium in patients at end of life. J Palliat Med, 2023; 26(6):826–830.
3.
ThummelKE, ShenDD, PodollTD, et al.Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients. J Pharmacol Exp Ther, 1994; 271(1):549–556.
